Search Results for 'collaboration'
-
Breaking News | Collaborations & Alliances | Drug Development | Industry News
Adragos Pharma Acquires Clinigen's Development Unit, Lamda Laboratories
Significantly expands Adragos' pharmaceutical product development, regulatory affairs and supply chain management services.03.27.23
-
Breaking News | Collaborations & Alliances
Vantage Nutrition Acquires ComboCap
Expands Vantage’s technology and customer solutions footprint in North America and around the world.03.27.23
-
Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery
Secarna, SciNeuro Enter Research Agreement for CNS Diseases
Secarna will employ its commercially validated locked nucleic acid discovery and development platform, LNAplus.03.27.23
-
APIs | Breaking News | Collaborations & Alliances | Industry News
Willow, Suanfarma Complete Manufacturing Process for Cannabigerol
CBG is clinically tested to be safe and has been shown to act as a potent antioxidant, anti-inflammatory and anti-microbial.03.24.23
-
Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery
Macomics, Ono Pharmaceutical Partner to Develop Immuno-oncology Antibody Drugs
Macomics will develop antibody candidates against a novel target using its ENIGMAC macrophage drug discovery platform.03.23.23
-
Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery
Moderna, Generation Bio Partner to Develop Non-Viral Genetic Medicines
Aims to expand the application of each company's platform by developing novel nucleic acid therapeutics, including those capable of reaching immune cells.03.23.23
-
Breaking News | cGMP Manufacture | Collaborations & Alliances
Hovione, Laxxon Medical Partner on 3D Screen Printed Pharmaceutical Apps
The alliance will create an opportunity for the pharmaceutical industry to develop and manufacture clinical materials and secure industrial scale production under cGMP.03.22.23
-
Breaking News | Collaborations & Alliances | Drug Delivery
Diabeloop, Novo Nordisk Partner on Next-Gen Insulin Pens
To integrate Diabeloop's self-learning algorithm for MDI therapy with Novo Nordisk's connected and reusable insulin pens.03.21.23
-
Breaking News | Collaborations & Alliances | Drug Delivery | Fill/Finish | Industry News
Stevanato Group, Thermo Fisher Partner to Bring On-Body Delivery System to Market
The companies will offer an integrated device and fill-and-finish solution to streamline the management of the pharmaceutical supply chain.03.21.23
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development
BioNTech, OncoC4 Partner to Develop mAb Candidate ONC-392 in Cancer
OncoC4 will receive a $200 million upfront and is eligible to receive development, regulatory and commercial milestone payments as well as royalties.03.20.23
-
Breaking News | Collaborations & Alliances | Drug Delivery
Hovione, Ripple Enter Strategic Drug Delivery Pact
Partnership aims to expand the use of Ripple's Epidel platform beyond ophthalmic applications.03.20.23
-
Breaking News | Collaborations & Alliances | Drug Discovery | Industry News
UCB, Aitia Enter Strategic Drug Discovery Alliance in Huntington's Disease
Will combine drug targets from Aitia's Gemini Digital Twins with UCB's expertise in drug research and preclinical model systems in neurodegeneration.03.16.23
-
Breaking News | Collaborations & Alliances | Drug Delivery | Industry News | Injectables | Parenterals
Stevanato, Recipharm Partner to Develop Pre-fillable Syringes for Soft Mist Inhaler
Stevanato will support the development and production of pre-fillable syringes for use in Recipharm’s soft mist inhalers.03.16.23
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development
Synaffix Expands ADC Collaboration with MacroGenics
Expanded collaboration includes up to $2.2 billion in total potential payments plus tiered royalties on net sales.03.15.23
-
Breaking News | cGMP Manufacture | Collaborations & Alliances | Drug Development
Catamaran Bio, OmniaBio Partner to Advance Allogeneic CAR-NK Cell Therapies
To develop and manufacture Catamaran Bio’s allogeneic chimeric antigen receptor (CAR)-NK cell therapies for the treatment of solid tumors.03.14.23
-
cGMP Manufacture | Collaborations & Alliances | Industry News
Vitrian, The Howard Hughes Corp. Partner to Develop Life Science Projects
The venture aims to meet the needs of companies focused on in-house manufacturing (from biopharma to industrial biology) as well as CDMOs.03.13.23
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Cytovance, Phenotypeca Partner to Enhance Strain Development for Microbial Biomanufacturing
Alliance aims to accelerate the development of high-performance yeast strains and to improve the efficiency of biologics production.03.13.23
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development | Industry News | R&D
Porton Advanced, Bennu Biotherapeutics Partner to Advance Cell Therapy R&D
Porton Advanced will provide CDMO services for multiple pipelines for gene and cell therapy, including plasmids, virus, TIL, TCR-T, and Treg03.13.23
-
Breaking News | Collaborations & Alliances | Drug Development | Industry News
Simris Alg, Lonza Partner to Promote ADC Payload Technology
Lonza granted global exclusive rights to offer Simris' ADC technology to biopharmaceutical companies.03.10.23
-
Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery
Crown Bioscience Opens Singapore Lab, Partners with JSR Life Sciences
The new facility will offer a broad portfolio of high-demand cell line-derived xenograft (CDX) and syngeneic models.03.10.23
-
Breaking News | cGMP Manufacture | Clinical Trial Materials | Collaborations & Alliances | Drug Development
Shuttle Pharma, UI Pharma Partner to Manufacture Ropidoxuridine
UI Pharma to provide formulation development and clinical batch manufacture of Ropidoxuridine capsules for Phase II trial in glioblastoma.03.09.23
-
Breaking News | cGMP Manufacture | Collaborations & Alliances | Drug Development | Industry News
GTP Bioways, Texcell Partner to Provide Extended CDMO and CRO Services
Alliance brings together process development and GMP manufacturing of biopharmaceuticals and viral testing, viral clearance, and bioassays.03.09.23
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Collaborations & Alliances
Cell One Partners, Center for Breakthrough Medicines Partner to Accelerate CGT Commercialization
Combines virtual executive leadership and program management with industry-leading capabilities and capacity for development and manufacturing of therapies.03.09.23
-
Breaking News | Collaborations & Alliances | Drug Development
Tessa Therapeutics Enters CRADA with the National Cancer Institute
To support investigation of Tessa’s lead allogeneic cell therapy, TT11X, in several subtypes of non-Hodgkin lymphoma.03.08.23
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances
Akston Biosciences Ends Vaccine Partnership with Stelis
Akston has reclaimed all commercial rights to AKS-452, its room temperature stable COVID-19 vaccine.03.08.23
-
Breaking News | Collaborations & Alliances | Drug Development
Korro Bio, Genevant to Develop RNA Editing Therapeutic for Alpha-1 Antitrypsin Deficiency
Collaboration to combine Korro’s RNA editing technology and Genevant’s LNP technology.03.07.23
-
Breaking News | Collaborations & Alliances | Drug Development
Caris Life Sciences, Incyte Partner to Advance Incyte's Oncology Pipeline
Partnership will apply Caris’ data and analytics tools, comprehensive molecular tissue and liquid profiling services.03.07.23
-
Breaking News | Collaborations & Alliances | Drug Development
Grifols, Selagine Partner to Develop Immunoglobulin Eye Drops
Grifols will have worldwide exclusive commercial rights to Selagine’s treatment.03.06.23
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Porton Advanced CDMO Collaborates with DanausGT
To accelerate the development of cell and gene therapies.03.03.23
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development | Industry News
IAVI, BARDA Expand Partnership to Advance Filovirus Vaccine Candidates
The funding from BARDA will enable IAVI to continue critical development and testing of filovirus vaccine candidates to facilitate better preparedness.03.02.23
-
Breaking News | Collaborations & Alliances | Drug Discovery | Information Technology
Tempus, Pfizer Enter Strategic AI Alliance in Oncology
Pfizer has access to Tempus’ AI-enabled platform and its library of de-identified, multimodal data to uncover insights for therapeutic development.02.28.23
-
Breaking News | Collaborations & Alliances | Drug Development | Information Technology
Lantern Pharma, TTC Oncology Partner to Advance Breast Cancer Drug with AI
Partnership to leverage Lantern’s AI platform to help accelerate and sharpen the development of TTC Oncology’s TTC-352 candidate.02.27.23
-
Breaking News | Collaborations & Alliances | Drug Development | Industry News | R&D
ZeClinics Moves Headquarters to Almirall R&D Centre
ZeClinics will leverage Almirall's state-of-the-art technology facilities to accelerate drug discovery by providing high-throughput safety and efficacy screenings.02.27.23
-
Bio News | Breaking News | cGMP Manufacture | Collaborations & Alliances | Drug Development
USP, Pharmatech Partner to Provide PCM Capabilities for Drug Developers/Manufacturers
The alliance will result in additional development capability and expertise to assist the pharmaceutical industry in implementing PCM processes.02.24.23
-
Bio News | Breaking News | Collaborations & Alliances | Drug Development | Industry News
Porton Advanced, Yinjia Biosciences Partner to Enhance CDMO Technology Platform
Yinjia Biosciences will provide Porton Advanced with high-quality core protein raw materials and testing reagent products for quality control and evaluation systems.02.24.23
-
Breaking News | Collaborations & Alliances | Drug Development | Industry News
Predictive Oncology, Cvergenx Partner on Genomics-based AI Approach to Personalized Radiotherapy
The strategic partnership may potentially lead to the repurposing of existing compounds or the development of an entirely new class of drugs.02.23.23
-
Breaking News | Collaborations & Alliances | Drug Development | Industry News
AbbVie, Capsida Expand Strategic Pact to Develop Genetic Medicines for Eye Diseases
Partnership combines AbbVie’s extensive capabilities with Capsida’s novel adeno-associated virus (AAV) engineering platform.02.23.23
-
Breaking News | Collaborations & Alliances | Drug Development
Keymed, Lepu Biopharma Enter Global License Agreement with AstraZeneca for CMG901
AstraZeneca will be responsible for the research, development, manufacture and commercialization of CMG901 globally.02.23.23
-
APIs | Breaking News | Collaborations & Alliances
Olon, Dept. of Chemistry at Politecnico di Milano to Study Polymorphism of the Solid State
The project will focus on new knowledge on the polymorphism of active ingredients and the advancement of methods for characterizing the solid state of their molecules.02.22.23
-
Breaking News | cGMP Manufacture | Collaborations & Alliances | Drug Development
CBM, Virion Partner on CD8+ T cell-based Clinical Development Programs
CBM will manufacture and partner with Virion on their checkpoint modifier clinical development programs, including the First-in-Human VRON-0200 immunotherapy.02.22.23
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Clinical Trial Materials | Collaborations & Alliances
GenScript ProBio, RVAC Medicines Enter GMP Plasmid DNA Manufacturing Pact
Alliance will enable GenScript ProBio to accelerate its clinical manufacturing of mRNA-based COVID-19 vaccine, RVM-V001.02.22.23
-
Breaking News | Collaborations & Alliances | Drug Development
Moderna, Life Edit Partner on In Vivo Gene Therapies
Collaboration combines Moderna's mRNA platform with Life Edit's gene editing technologies, including base editing capabilities.02.22.23
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News
LIfT BioSciences, Minaris Regenerative Enter Cell Therapy Partnership
The two companies will develop a GMP-compliant manufacturing process to supply LIfT’s clinical trial programs in Europe.02.17.23
-
Breaking News | Collaborations & Alliances | Industry News
Charles River, Purespring Collaborate on Gene Therapy Manufacturing
Plasmid CDMO alliance supports first gene therapy platform targeting kidney diseases.02.16.23
-
Bio News | Biosimilars | Breaking News | Collaborations & Alliances | Drug Development | Industry News
Similis Bio Partners With Novel351k to Develop Multiple Biosimilar Programs
Novel351k will leverage its experience with regulatory and clinical strategies to accelerate the development of the programs toward commercialization.02.15.23
-
Breaking News | Collaborations & Alliances | Drug Discovery | Industry News
Takeda Acquires Nimbus Therapeutics TYK2 Program Subsidiary
The acquisition strengthens Takeda’s growing late-stage pipeline, expands portfolio, and patient impact across multiple indications.02.10.23
-
Breaking News | Collaborations & Alliances | Industry News | Information Technology
SEEQC Joins Forces with BASF to Explore Applications of Quantum Computing
Alliance increases quantum computing development for chemical, pharmaceutical industries.02.10.23
-
Breaking News | Collaborations & Alliances | Industry News | Packaging & Tracking | Vials
West Expands Corning Alliance, Launches First Product
The partnership combines West's NovaPure stoppers, Flip-Off CCS seals and Corning's Valor RTU Vials with SG EZ-fill technology.02.10.23
-
Breaking News | Collaborations & Alliances | Drug Discovery | Industry News
Element Biosciences, Bio-Rad Partner to Deliver Seamless Sequencing
The SEQuoia Express Stranded RNA Library Prep Kit offers the additional benefit of an efficient 3-tube workflow for detection of long RNAs.02.09.23
-
Breaking News | Collaborations & Alliances | Industry News
Bio Immunitas Enters Manufacturing Collaboration with GenScript ProBio
The partnership will fast-track Bio Immunitas' manufacturing and production from bench to bedside in an expedited timescale while maintaining regulatory milestones.02.09.23
